E-Cadherin/β-Catenin/T-cell factor pathway is involved in smooth muscle cell proliferation elicited by oxidized low-density lipoprotein

Circulation Research

Volumn 103, Issue 7, 2008, Pages 694-701

  Bedel, Aurélie ^a   Nègre Salvayre, Anne ^a   Heeneman, Sylvia ^c   Grazide, Marie Hélène ^a   Thiers, Jean Claude ^a   Salvayre, Robert ^a   Maupas Schwalm, Françoise ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

catenin signaling pathway; Atherosclerosis; Oxidized LDL

Indexed keywords

BETA CATENIN; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCOGEN SYNTHASE KINASE 3BETA; KI 67 ANTIGEN; MATRIX METALLOPROTEINASE 14; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; T CELL FACTOR PROTEIN; UVOMORULIN; BIOLOGICAL MARKER; CADHERIN; CYCLIN D; CYCLINE; DNA; LOW DENSITY LIPOPROTEIN; MATRIX METALLOPROTEINASE; PHOSPHOTRANSFERASE; PROTEASOME;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; AORTA; BIOSYNTHESIS; CAROTID ARTERY; CELL CULTURE; CELL CYCLE; CELL TRANSFORMATION; DRUG ANTAGONISM; DRUG EFFECT; EMBRYO DEVELOPMENT; METABOLISM; PHOSPHORYLATION;

AORTA; ATHEROSCLEROSIS; BETA CATENIN; BIOLOGICAL MARKERS; CADHERINS; CAROTID ARTERIES; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CYCLINS; DNA; EMBRYONIC DEVELOPMENT; ENZYME ACTIVATION; HUMANS; KI-67 ANTIGEN; LIPOPROTEINS, LDL; MATRIX METALLOPROTEINASES; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; PHOSPHOTRANSFERASES; PROTEASOME ENDOPEPTIDASE COMPLEX; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS;

EID: 54449090026     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.107.166405     Document Type: Article

References (48)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340: 115-126.
2. Libby P. Atherosclerosis: disease biology affecting the coronary vascu-lature. Am J Cardiol. 2006;98:3Q-9Q.
3. Fuster V, Moreno PR, Fayad ZA, Corti R, Badimon JJ. Atherothrombosis and high-risk plaque: part I: evolving concepts. J Am Coll Cardiol. 2005;46:937-954.
4. Lusis AJ. Atherosclerosis. Nature. 2000;407:233-241.
5. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 1997;272:20963-20966.
6. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
7. Chisolm GM, Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med. 2000;28:1815-1826.
8. Auge N, Garcia V, Maupas-Schwalm F, Levade T, Salvayre R, Negre-Salvayre A. Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the sphingolipid signaling pathways. Arterioscler Thromb Vasc Biol. 2002;22:1990-1995.
9. Auge N, Maupas-Schwalm F, Elbaz M, Thiers JC, Waysbort A, Itohara S, Krell HW, Salvayre R, Negre-Salvayre A. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ ceramide pathway and smooth muscle cell proliferation. Circulation. 2004;110:571-578.
10. Levade T, Auge N, Veldman RJ, Cuvillier O, Negre-Salvayre A, Salvayre R. Sphingolipid mediators in cardiovascular cell biology and pathology. Circ Res. 2001;89:957-968.
11. Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta. 2003;1653:1-24.
12. Ozawa M, Kemler R. The membrane-proximal region of the E-cadherin cytoplasmic domain prevents dimerization and negatively regulates adhesion activity. J Cell Biol. 1998;142:1605-1613.
13. Ozawa M, Ringwald M, Kemler R. Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc Natl Acad Sci U S A. 1990;87:4246-4250.
14. Nagafuchi A, Takeichi M. Cell binding function of E-cadherin is regulated by the cytoplasmic domain. EMBO J. 1988;7:3679-3684.
15. Herrenknecht K, Ozawa M, Eckerskorn C, Lottspeich F, Lenter M, Kemler R. The uvomorulin-anchorage protein alpha catenin is a vinculin homologue. Proc Natl Acad Sci U S A. 1991;88:9156-9160.
16. Kinch MS, Clark GJ, Der CJ, Burridge K. Tyrosine phosphorylation regulates the adhesions of ras-transformed breast epithelia. J Cell Biol. 1995;130:461-471.
17. Hoschuetzky H, Aberle H, Kemler R. Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor. J Cell Biol. 1994;127:1375-1380.
18. van de Wetering M, Cavallo R, Dooijes D, van Beest M, van Es J, Loureiro J, Ypma A, Hursh D, Jones T, Bejsovec A, Peifer M, Mortin M, Clevers H. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell. 1997;88:789-799.
19. Quasnichka H, Slater SC, Beeching CA, Boehm M, Sala-Newby GB, George SJ. Regulation of smooth muscle cell proliferation by beta-catenin/T-cell factor signaling involves modulation of cyclin D1 and p21 expression. Circ Res. 2006;99:1329-1337.
20. Couffinhal T, Dufourcq P, Duplaa C. Beta-catenin nuclear activation: common pathway between Wnt and growth factor signaling in vascular smooth muscle cell proliferation? Circ Res. 2006;99:1287-1289.
21. Auge N, Pieraggi MT, Thiers JC, Negre-Salvayre A, Salvayre R. Prolif-erative and cytotoxic effects of mildly oxidized low-density lipoproteins on vascular smooth-muscle cells. Biochem J. 1995;309(pt 3):1015-1020.
22. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and athero-genesis: the good, the bad, and the ugly. Circ Res. 2002;90:251-262.
23. Myers SJ, Stanley KK. Src family kinase activation in glycosphingolipid-rich membrane domains of endothelial cells treated with oxidised low density lipoprotein. Atherosclerosis. 1999;143:389-397.
24. Lilien J, Balsamo J. The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin. Curr Opin Cell Biol. 2005;17:459-465.
25. Maupas-Schwalm F, Robinet C, Auge N, Thiers JC, Garcia V, Cambus JP, Salvayre R, Negre-Salvayre A. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells. Cancer Res. 2005; 65:526-532.
26. Ishizawar RC, Miyake T, Parsons SJ. c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function. Oncogene. 2007;26:3503-3510.
27. Sigala F, Vourliotakis G, Georgopoulos S, Kavantzas N, Papalambros E, Agapitos M, Bastounis E. Vascular endothelial cadherin expression in human carotid atherosclerotic plaque and its relationship with plaque morphology and clinical data. Eur J Vasc Endovasc Surg. 2003;26: 523-528.
28. Chung AW, Luo H, Tejerina T, van Breemen C, Okon EB. Enhanced cell cycle entry and mitogen-activated protein kinase-signaling and down-regulation of matrix metalloproteinase-1 and-3 in human diabetic arterial vasculature. Atherosclerosis. 2007;195:e1-e8.
29. Slater SC, Koutsouki E, Jackson CL, Bush RC, Angelini GD, Newby AC, George SJ. R-cadherin:beta-catenin complex and its association with vascular smooth muscle cell proliferation. Arterioscler Thromb Vasc Biol. 2004;24:1204-1210.
30. Kim KI, Cho HJ, Hahn JY, Kim TY, Park KW, Koo BK, Shin CS, Kim CH, Oh BH, Lee MM, Park YB, Kim HS. Beta-catenin overexpression augments angiogenesis and skeletal muscle regeneration through dual mechanism of vascular endothelial growth factor-mediated endothelial cell proliferation and progenitor cell mobilization. Arterioscler Thromb Vasc Biol. 2006;26:91-98.
31. George SJ, Beeching CA. Cadherin:catenin complex: a novel regulator of vascular smooth muscle cell behaviour. Atherosclerosis. 2006;188:1-11.
32. Negre-Salvayre A, Vieira O, Escargueil-Blanc I, Salvayre R. Oxidized LDL and 4-hydroxynonenal modulate tyrosine kinase receptor activity. Mol Aspects Med. 2003;24:251-261.
33. Nusse R. Cell biology: relays at the membrane. Nature. 2005;438: 747-749.
34. Irby RB, Yeatman TJ. Increased Src activity disrupts cadherin/catenin- mediated homotypic adhesion in human colon cancer and transformed rodent cells. Cancer Res. 2002;62:2669-2674.
35. Hashimoto K, Kataoka N, Nakamura E, Tsujioka K, Kajiya F. Oxidized LDL specifically promotes the initiation of monocyte invasion during transendothelial migration with upregulated PECAM-1 and down-regulated VE-cadherin on endothelial junctions. Atherosclerosis. 2007; 194:e9-e17.
36. Avizienyte E, Wyke AW, Jones RJ, McLean GW, Westhoff MA, Brunton VG, Frame MC. Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling. Nat Cell Biol. 2002;4:632-638.
37. Yang JY, Zong CS, Xia W, Wei Y, Ali-Seyed M, Li Z, Broglio K, Berry DA, Hung MC. MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation. Mol Cell Biol. 2006;26:7269-7282.
38. Covington MD, Burghardt RC, Parrish AR. Ischemia-induced cleavage of cadherins in NRK cells requires MT1-MMP (MMP-14). Am J Physiol Renal Physiol. 2006;290:F43-F51.
39. Ara T, Deyama Y, Yoshimura Y, Higashino F, Shindoh M, Matsumoto A, Fukuda H. Membrane type 1-matrix metalloproteinase expression is regulated by E-cadherin through the suppression of mitogen-activated protein kinase cascade. Cancer Lett. 2000;157:115-121.
40. Nawrocki-Raby B, Gilles C, Polette M, Martinella-Catusse C, Bonnet N, Puchelle E, Foidart JM, Van Roy F, Birembaut P. E-Cadherin mediates MMP down-regulation in highly invasive bronchial tumor cells. Am J Pathol. 2003;163:653-661.
41. Pece S, Chiariello M, Murga C, Gutkind JS. Activation of the protein kinase Akt/PKB by the formation of E-cadherin-mediated cell-cell junctions. Evidence for the association of phosphatidylinositol 3-kinase with the E-cadherin adhesion complex. J Biol Chem. 1999;274: 19347-19351.
42. Cohen P, Frame S. The renaissance of GSK3. Nat Rev Mol Cell Biol. 2001;2:769-776.
43. Fang D, Hawke D, Zheng Y, Xia Y, Meisenhelder J, Nika H, Mills GB, Kobayashi R, Hunter T, Lu Z. Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity. J Biol Chem. 2007;282: 11221-11229.
44. Asally M, Yoneda Y. Beta-catenin can act as a nuclear import receptor for its partner transcription factor, lymphocyte enhancer factor-1 (lef-1). Exp Cell Res. 2005;308:357-363.
45. Krieghoff E, Behrens J, Mayr B. Nucleo-cytoplasmic distribution of beta-catenin is regulated by retention. J Cell Sci. 2006;119:1453-1463.
46. Hagen T, Sethi JK, Foxwell N, Vidal-Puig A. Signalling activity of beta-catenin targeted to different subcellular compartments. Biochem J. 2004;379:471-477.
47. Henderson BR, Fagotto F. The ins and outs of APC and beta-catenin nuclear transport. EMBO Rep. 2002;3:834-839.
48. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D?Amico M, Pestell R, Ben-Ze?ev A. The cyclin D1 gene is a target of the /3-catenin/LEF-1 pathway. Proc Natl Acad Sci USA. 1999;96:5522-5527.